A virtual phenotype test provides the same information as a genotype test.
In this Section
How to Read a virco®TYPE
HIV-1 v4.3.01 HIV-1 Report
HIV-1 v4.3.01 HIV-1 Report
HIV Education > Virco Product Monograph
Virco Product Monograph
The virco® TYPE HIV-1 Report provides clinicians with quantitative HIV resistance information to assist them in making informed treatment decision for patents living with HIV/AIDS.
The following product monograph has been divided into five units as toolkits which were created by Virco to explain the rationale for developing the virco®TYPE HIV-1 Report and to assist HIV clinicians in better understanding the analytical processes used to transform an abundance of data into relevant clinical information.
Introduction to
Resistance Testing
Generating a
virco®TYPE HIV-1 Report
Clinical Cut-Offs,
Virco's Approach
How to Read and Use the
virco®TYPE HIV-1 Report
Highly Treatment Experienced
Patient Example
How to Read and Use the
virco®TYPE HIV-1 Report
Less Complex Example
Introduces three commercially available modalities of resistance testing and describes the data generated by each
Adobe Acrobat Format 
Microsoft Powerpoint Format(powerpoint version contains slide notes)
Describes the methodologies employed by Virco to calculate fold-change values (a quantitative measure of HIV drug resistance) from its extensive correlative database of genotypes and phenotypes on clinical isolates.
Adobe Acrobat Format Microsoft Powerpoint Format (powerpoint version contains slide notes)
Describes the data and methods used by Virco to establish the clinical cut-offs that are used to assess patient results on the virco®TYPE HIV-1 report.
Adobe Acrobat Format Microsoft Powerpoint Format (powerpoint version contains slide notes)
Provides a detailed explanation of how to read and use the virco®TYPE HIV-1 Report
Adobe Acrobat Format Microsoft Powerpoint Format(powerpoint version contains slide notes)
Provides a detailed explanation of how to read and use the virco® TYPE HIV-1 Report using a less experienced patient example.
Adobe Acrobat Format Microsoft Powerpoint Format(powerpoint version contains slide notes)
What's New
These modules are presented in an easy to navigate format and begin with a history of the HIV/AIDS epidemic and current epidemiology.
November 2009
Volume 1, Number 3
Presented by Dr. Rafael E. Campo
A 49-year-old African American male, with a history of IDU, unexpectedly presents to the clinic with viremia and declining CD4 cell count after being lost to follow-up for 2.5 years..
Updated December 1, 2009 — Antiretroviral Guidelines for Adults and Adolescents: Drug Resistance Testing